Neurokinin 1 receptor isoforms and the control of innate immunity

Trends in Immunology

Volumn 30, Issue 6, 2009, Pages 271-276

  Tuluc, Florin ^a,b   Lai, Jian Ping ^a   Kilpatrick, Laurie E ^a,b   Evans, Dwight L ^b   Douglas, Steven D ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ALTERNATIVE SPLICING; ANIMALS; CHEMOTAXIS; CYTOKINES; DRUG THERAPY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; MACROPHAGES; PROTEIN ISOFORMS; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VIRUS REPLICATION;

EID: 66549125635     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.03.006     Document Type: Review

References (51)

1. Bost K.L. Tachykinin-mediated modulation of the immune response. Front. Biosci. 9 (2004) 3331-3332
2. Ho W.Z., et al. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159 (1997) 5654-5660
3. Satake H., and Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr. Drug Targets 7 (2006) 963-974
4. Page N.M. New challenges in the study of the mammalian tachykinins. Peptides 26 (2005) 1356-1368
5. Zimmer G., et al. Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus. J. Biol. Chem. 278 (2003) 46854-46861
6. Pennefather J.N., et al. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74 (2004) 1445-1463
7. Page N.M. Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides. Vascul. Pharmacol. 45 (2006) 200-208
8. Werge T. The tachykinin tale: molecular recognition in a historical perspective. J. Mol. Recognit. 20 (2007) 145-153
9. Fong T.M., et al. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 41 (1992) 24-30
10. Caberlotto L., et al. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur. J. Neurosci. 17 (2003) 1736-1746
11. Almeida T.A., et al. Tachykinins and tachykinin receptors: structure and activity relationships. Curr. Med. Chem. 11 (2004) 2045-2081
12. O'Connor T.M., et al. The role of substance P in inflammatory disease. J. Cell. Physiol. 201 (2004) 167-180
13. Palma C. Tachykinins and their receptors in human malignancies. Curr. Drug Targets 7 (2006) 1043-1052
14. Chahl L.A. Tachykinins and neuropsychiatric disorders. Curr. Drug Targets 7 (2006) 993-1003
15. Zhang Y., et al. Tachykinins in the immune system. Curr. Drug Targets 7 (2006) 1011-1020
16. Ebner K., and Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 31 (2006) 251-272
17. Bohm S.K., et al. Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor. J. Biol. Chem. 272 (1997) 2363-2372
18. Li H., et al. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9475-9480
19. DeFea K.A., et al. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11086-11091
20. Lai J.P., et al. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86 (1998) 80-86
21. Lai J.P., et al. Detection of substance P and its receptor in human fetal microglia. Neuroscience 101 (2000) 1137-1144
22. Li Y., et al. Human stem cells express substance P gene and its receptor. J. Hematother. Stem Cell Res. 9 (2000) 445-452
23. Li Y., et al. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression. J. Neurosci. Res. 71 (2003) 559-566
24. Ho W.Z., et al. HIV enhances substance P expression in human immune cells. FASEB J. 16 (2002) 616-618
25. Ho W.-Z., and Douglas S.D. Substance P and neurokinin-1 receptor modulation of HIV. J. Neuroimmunol. 157 (2004) 48-55
26. Goode T., et al. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin. Diagn. Lab. Immunol. 7 (2000) 371-376
27. Evans D.L., et al. Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol. Psychiatry 63 (2008) 899-905
28. Rameshwar P., et al. In vitro stimulatory effect of substance P on hematopoiesis. Blood 81 (1993) 391-398
29. Berger A., et al. Co-regulated decrease of Neurokinin-1 receptor and Hemokinin-1 gene expression in monocytes and macrophages after activation with pro-inflammatory cytokines. J. Neuroimmunol. 187 (2007) 83-93
30. Douglas S.D., et al. Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals. J. Neurol. Sci. 272 (2008) 174-177
31. Chernova I., et al. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R). J. leukocyte boil (2008)
32. Lai J.P., et al. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7771-7776
33. Lai J.P., et al. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 12605-12610
34. Gross B., and Staels B. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 21 4 (2007) 687-710
35. Straus D.S., and Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 28 (2007) 551-558
36. Reddy R.C. Immunomodulatory role of PPAR-gamma in alveolar macrophages. J. Investig. Med. 56 (2008) 522-527
37. Daynes R.A., and Jones D.C. Emerging roles of PPARs in inflammation and immunity. Natl. Rev. 2 (2002) 748-759
38. Delerive P., et al. Peroxisome proliferator-activated receptors in inflammation control. J. Endocrinol. 169 (2001) 453-459
39. Amoruso A., et al. A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages. Br. J. Pharmacol. 154 (2008) 144-152
40. Bost K.L. Tachykinin-modulated anti-viral responses. Front. Biosci. 9 (2004) 1994-1998
41. Douglas S.D., et al. Elevated substance P levels in HIV-infected men. AIDS 15 (2001) 2043-2045
42. Douglas S.D., et al. Elevated substance P levels in HIV-infected women in comparison to HIV-negative women. AIDS Res. Hum. Retroviruses 24 (2008) 375-378
43. Lai J.P., et al. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc. Natl. Acad. Sci. U. S. A 98 (2001) 3970-3975
44. Manak, M. et al. (2008) Anti-HIV Activity of Aprepitant and Synergistic interactions with other Antiretrovirals. In 15th Conference on Retroviruses and Opportunistic Infections
45. Wang X., et al. Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro. J. Neuroimmune Pharmacol. 2 (2007) 42-48
46. Hamza M.A., et al. Herpes simplex virus type-1 latency-associated transcript-induced immunoreactivity of substance P in trigeminal neurons is reversed by bone morphogenetic protein-7. Neurosci. Lett. 413 (2007) 31-35
47. Svensson A., et al. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. J. Immunol. 175 (2005) 6802-6811
48. Tansky M.F., et al. Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10691-10696
49. Randolph G.P., et al. Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant. Pharmacogenomics J. 4 (2004) 394-402
50. Nakajima Y., et al. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J. Biol. Chem. 267 (1992) 2437-2442
51. Laniyonu A., et al. Different tachykinin receptor subtypes are coupled to the phosphoinositide or cyclic AMP signal transduction pathways in rat submandibular cells. FEBS Lett. 240 (1988) 186-190